0001077183-20-000024.txt : 20200228
0001077183-20-000024.hdr.sgml : 20200228
20200228175347
ACCESSION NUMBER: 0001077183-20-000024
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200219
FILED AS OF DATE: 20200228
DATE AS OF CHANGE: 20200228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pedulla Denise E
CENTRAL INDEX KEY: 0001804602
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35756
FILM NUMBER: 20672926
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEOGENOMICS INC
CENTRAL INDEX KEY: 0001077183
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734]
IRS NUMBER: 742897368
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
BUSINESS PHONE: 9419231949
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC
DATE OF NAME CHANGE: 19990120
3
1
wf-form3_158293041092276.xml
FORM 3
X0206
3
2020-02-19
0
0001077183
NEOGENOMICS INC
NEO
0001804602
Pedulla Denise E
12701 COMMONWEALTH DRIVE
SUITE 9
FORT MYERS
FL
33913
0
1
0
0
General Counsel
Common Stock
41076
D
Common Stock
7.85
2016-12-08
2020-12-08
Common Stock
15000.0
D
Common Stock
7.52
2018-04-28
2022-04-28
Common Stock
25000.0
D
Common Stock
8.03
2019-02-26
2023-02-26
Common Stock
48334.0
D
Common Stock
19.6
2020-03-01
2024-03-01
Common Stock
17496.0
D
On December 8, 2015, Ms. Pedulla was granted an option to purchase 60,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first four anniversary dates of the grant date.
On April 28, 2017, Ms. Pedulla was granted an option to purchase 75,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.
On January 26, 2018, Ms. Pedulla was granted an option to purchase 72,500 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.
On March 1, 2019, Ms. Pedulla was granted an option to purchase 17,496 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first four anniversary dates of the grant date.
/s/ Denise E Pedulla
2020-02-28